These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38641834)

  • 1. A randomized controlled trial to compare short-term outcomes following infragastric and infracolic omentectomy at the time of primary debulking surgery for epithelial ovarian cancer with normal-appearing omentum.
    Dong X; Yuan L; Zou R; Yao L
    J Ovarian Res; 2024 Apr; 17(1):85. PubMed ID: 38641834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The omentum and omentectomy in epithelial ovarian cancer: a reappraisal: part II--The role of omentectomy in the staging and treatment of apparent early stage epithelial ovarian cancer.
    Arie AB; McNally L; Kapp DS; Teng NN
    Gynecol Oncol; 2013 Dec; 131(3):784-90. PubMed ID: 24056005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total Infragastric Omentectomy Including the Vascular Perigastric Arcade in Patients With Advanced Serous Ovarian Tumors.
    Cordeiro Vidal G; Croce S; Guyon F; Babin G; Querleu D
    Int J Gynecol Cancer; 2017 Feb; 27(2):252-257. PubMed ID: 28114233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The omentum and omentectomy in epithelial ovarian cancer: a reappraisal. Part I--Omental function and history of omentectomy.
    Ben Arie A; McNally L; Kapp DS; Teng NN
    Gynecol Oncol; 2013 Dec; 131(3):780-3. PubMed ID: 24056004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Surgery in early-stage ovarian cancer: Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa].
    Bolze PA; Collinet P; Golfier F; Bourgin C
    Gynecol Obstet Fertil Senol; 2019 Feb; 47(2):168-179. PubMed ID: 30686727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does omentectomy in epithelial ovarian cancer affect survival? An analysis of the Surveillance, Epidemiology, and End Results database.
    McNally L; Teng NN; Kapp DS; Karam A
    Int J Gynecol Cancer; 2015 May; 25(4):607-15. PubMed ID: 25756404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of omentectomy and random peritoneal biopsies as part of comprehensive surgical staging in apparent early-stage epithelial ovarian cancer.
    Lee JY; Kim HS; Chung HH; Kim JW; Park NH; Song YS
    Ann Surg Oncol; 2014 Aug; 21(8):2762-6. PubMed ID: 24770785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Influence of "Omental Cake" Presence on the Completeness of Cytoreduction in Advanced-stage Ovarian Cancer.
    Bacalbasa N; Diaconu C; Iliescu L; Savu C; Bratu OG; Bolca C; Cretoiu D; Filipescu A; Dima S; Balalau C; Balescu I
    In Vivo; 2020; 34(4):2187-2191. PubMed ID: 32606203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robotic omentectomy in gynecologic oncology: surgical anatomy, indications, and a technical approach.
    Feuer G; Briskin C; Lakhi N
    J Robot Surg; 2023 Aug; 17(4):1381-1391. PubMed ID: 36648633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is routine omentectomy of grossly normal omentum helpful in surgery for ovarian cancer? A look at the tumor microenvironment and its clinical implications.
    Bilbao M; Aikins JK; Ostrovsky O
    Gynecol Oncol; 2021 Apr; 161(1):78-82. PubMed ID: 33436287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laparoscopic infragastric omentectomy in surgery of gynecologic malignant tumor.
    Dong X; Chen M; Yao L
    Int J Gynecol Cancer; 2023 Aug; 33(8):1318-1319. PubMed ID: 36787935
    [No Abstract]   [Full Text] [Related]  

  • 12. Study of upfront surgery versus neoadjuvant chemotherapy followed by interval debulking surgery for patients with stage IIIC and IV ovarian cancer, SGOG SUNNY (SOC-2) trial concept.
    Jiang R; Zhu J; Kim JW; Liu J; Kato K; Kim HS; Zhang Y; Zhang P; Zhu T; Aoki D; Yu A; Chen X; Wang X; Zhu D; Zhang W; Jia H; Shi T; Gao W; Yin S; Feng Y; Xiang L; Okamoto A; Zang R
    J Gynecol Oncol; 2020 Sep; 31(5):e86. PubMed ID: 32808504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supragastric lesser sac: an insidious site for surgical exploration during the debulking surgery in advanced ovarian cancer.
    Chen Y; Sun Z; Cai S; Hu Y; Jiang R; Xiang L; Zang R
    J Gynecol Oncol; 2024 May; 35(3):e25. PubMed ID: 38130134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultra-radical (extensive) surgery versus standard surgery for the primary cytoreduction of advanced epithelial ovarian cancer.
    Hiu S; Bryant A; Gajjar K; Kunonga PT; Naik R
    Cochrane Database Syst Rev; 2022 Aug; 8(8):CD007697. PubMed ID: 36041232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of omentectomy during the surgical staging in patients with clinical stage I endometrioid adenocarcinoma.
    Metindir J; Dilek GB
    J Cancer Res Clin Oncol; 2008 Oct; 134(10):1067-70. PubMed ID: 18386056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors of overall survival for patients with FIGO stage IIIc or IVa ovarian cancer treated with neo-adjuvant chemotherapy followed by interval debulking surgery: A multicenter cohort analysis from the FRANCOGYN study group.
    Vincent L; Jankowski C; Ouldamer L; Ballester M; Bendifallah S; Bolze PA; Akladios C; Costaz H; Lavoué V; Canlorbe G; Collinet P; Touboul C; Huchon C; Bricou A; Dridi S; Padéano MM; Bengrine L; Arnould L; Coutant C;
    Eur J Surg Oncol; 2020 Sep; 46(9):1689-1696. PubMed ID: 32417154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of bulky upper abdominal disease cephalad to the greater omentum on surgical outcome for stage IIIC epithelial ovarian, fallopian tube, and primary peritoneal cancer.
    Zivanovic O; Eisenhauer EL; Zhou Q; Iasonos A; Sabbatini P; Sonoda Y; Abu-Rustum NR; Barakat RR; Chi DS
    Gynecol Oncol; 2008 Feb; 108(2):287-92. PubMed ID: 17996927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimally invasive interval debulking surgery in ovarian neoplasm (MISSION trial-NCT02324595): a feasibility study.
    Gueli Alletti S; Bottoni C; Fanfani F; Gallotta V; Chiantera V; Costantini B; Cosentino F; Ercoli A; Scambia G; Fagotti A
    Am J Obstet Gynecol; 2016 Apr; 214(4):503.e1-503.e6. PubMed ID: 26529370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal debulking surgery is an independent prognostic factor in patients with FIGO IIIC primary epithelial ovarian carcinoma.
    Wang PH; Yuan CC; Shyong WY; Chiang SC; Chao JY; Yen MS; Ng HT
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Mar; 63(3):220-5. PubMed ID: 10746418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel classification of residual disease after interval debulking surgery for advanced-stage ovarian cancer to better distinguish oncologic outcome.
    Manning-Geist BL; Hicks-Courant K; Gockley AA; Clark RM; Del Carmen MG; Growdon WB; Horowitz NS; Berkowitz RS; Muto MG; Worley MJ
    Am J Obstet Gynecol; 2019 Oct; 221(4):326.e1-326.e7. PubMed ID: 31082382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.